Geezus - some real raging here.
let’s just see what happens next week. The rest is speculation.
for those frustrated with my comment of “priced in”, I hope it goes to $1 next week. I’ve been long for years. It’s been a journey. A tough one.
But from experience, I believe the upside of the approval is priced in, but the ability to commercialise and what that looks like post approval has not. This represents considerable further upside and it’s why I’m not selling.
Ann: Final Sofdra Labelling Discussions with FDA, page-74
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $624.4M | |||
| Open | High | Low | Value | Volume |
| 35.0¢ | 35.0¢ | 33.0¢ | $2.271M | 6.715M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 83805 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.5¢ | 112605 | 3 |
View Market Depth
| Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |